Onconetix, Inc. (ONCO)
0.38
-0.02
(-5.94%)
USD |
NASDAQ |
May 08, 16:00
0.3714
-0.01
(-2.26%)
After-Hours: 20:00
Onconetix EPS Diluted (Quarterly) : 18.17 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -0.1055 |
| Sensei Biotherapeutics, Inc. | -3.622 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.670M |
| Revenue (Quarterly) | 0.3036M |
| Total Expenses (Quarterly) | -5.366M |
| Enterprise Value | -4.898M |
| Gross Profit Margin (Quarterly) | 81.59% |
| Earnings Yield | -69.49K% |
| Normalized Earnings Yield | -41596.39 |